Latest Kaiser Health News Stories
Medicare limits payments for valve replacement via a catheter to hospitals with large numbers of heart procedures. But smaller facilities are crying foul.
Through a widely circulated brochure and a videotape of testimonials, the maker of OxyContin stressed patients’ right to opioid treatment for pain.
About a quarter of fraud investigator positions at the state Department of Insurance are open, and Steve Poizner has made the vacancies a focus of his campaign for insurance commissioner. His opponent, Ricardo Lara, says chasing criminals isn’t the only solution to rising health care costs.
Some hospitals have taken steps to be more energy-efficient. Though at times these changes barely represent rounding errors in their budgets, comprehensive efforts are beginning to make a difference.
A new study in JAMA Surgery finds that a large sample of published medical research failed to disclose details on the financial relationships between medical device makers and physicians. Changes in the disclosure process could close this loop.
Federal officials are proposing a rule to prohibit home health aides paid directly by Medicaid from having their dues for the powerful Service Employees International Union automatically deducted from their paychecks. The effort would likely mean those workers are far less likely to pay dues and could diminish the union’s influence.
The opioid epidemic has increased the number of donated organs. Until recently, though, organs from donors who died of drug overdoses were often discarded because an estimated 30 percent of them were infected with hepatitis C.
Newsletter editor Brianna Labuskes wades through hundreds of health articles from the week so you don’t have to.
In this episode of KHN’s “What the Health?” Julie Rovner of Kaiser Health News, Anna Edney of Bloomberg News, Margot Sanger-Katz of The New York Times and Kimberly Leonard of the Washington Examiner talk about the latest Trump administration efforts to address high drug prices, what’s next for short-term health insurance plans and insider trading charges against a New York GOP congressman.
A Kaiser Health News and USA Today Network investigation finds that a hodgepodge of state rules governing outpatient centers allow some deaths and serious injuries to go unexamined. And no rule stops a doctor exiled by a hospital for misconduct from opening a surgery center down the street.
Inspector general identifies possible problems in nearly 23 percent of pharmacies that bill Medicare for blended creams, gels and lotions.
Rep. Chris Collins talked one time too many, according to federal prosecutors who on Wednesday charged him with violating insider trading laws.
The number of diabetes drug prescriptions filled for low-income people enrolled in Medicaid rose sharply in states that expanded eligibility for the program under the Affordable Care Act, according to a new study.
The island’s government must squeeze $840.2 million in annual savings from Medicaid by 2023, part of the U.S. territory’s agreement with the federal government as Puerto Rico claws its way back from fiscal oblivion. Experts warn such drastic cuts defy actuarial science.
KHN’s newsletter editor, Brianna Labuskes, wades through hundreds of health articles from the week so you don’t have to.
Fentanyl and other painkillers marketed as safer than Purdue Pharma’s blockbuster drug left their own trail of overdose deaths.
The Trump administration signals it is willing to consider such a move if it is carefully tailored to focus solely on specific situations where a high-priced drug is made by one company.
With rising college costs, up to half of college students’ finances are stretched so tight they report that they were either not getting enough to eat or were worried about it, studies find.
A new government watchdog report outlines vulnerabilities in Medicare’s $17 billion hospice program, pointing to inadequate services, inappropriate billing and outright fraud.
After a USA Today Network-Kaiser Health News investigation, Medicare announced last week that it is re-evaluating whether these procedures “pose a significant safety risk” to patients.